26B-4-243.  Guidance for treatment with medical cannabis.
     The department, in consultation with the Center for Medical Cannabis Research created in Section 53B-17-1402, shall:

(1)  develop evidence-based guidance for treatment with medical cannabis based on the latest medical research that shall include:

Terms Used In Utah Code 26B-4-243

(a)  for each qualifying condition, a summary of the latest medical research regarding the treatment of the qualifying condition with medical cannabis;

(b)  risks, contraindications, side effects, and adverse reactions that are associated with medical cannabis use; and

(c)  potential drug interactions between medical cannabis and medications that have been approved by the United States Food and Drug Administration; and

(2)  educate recommending medical providers, pharmacy medical providers, medical cannabis cardholders, and the public regarding:

(a)  the evidence-based guidance for treatment with medical cannabis described in Subsection (1)(a);

(b)  relevant warnings and safety information related to medical cannabis use; and

(c)  other topics related to medical cannabis use as determined by the department.

Enacted by Chapter 281, 2023 General Session

Technical renumber of section for proper placement in Title and Chapter.

  Previous section
Next section  
 Part 2 Contents